These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27837434)

  • 1. Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters.
    Nakae S; Murayama K; Sasaki H; Kumon M; Nishiyama Y; Ohba S; Adachi K; Nagahisa S; Hayashi T; Inamasu J; Abe M; Hasegawa M; Hirose Y
    J Neurooncol; 2017 Jan; 131(2):403-412. PubMed ID: 27837434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas.
    Nakae S; Sasaki H; Hayashi S; Hattori N; Kumon M; Nishiyama Y; Adachi K; Nagahisa S; Hayashi T; Inamasu J; Abe M; Hasegawa M; Hirose Y
    PLoS One; 2015; 10(11):e0142750. PubMed ID: 26558387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas.
    Ohba S; Murayama K; Kuwahara K; Pareira ES; Nakae S; Nishiyama Y; Adachi K; Yamada S; Sasaki H; Yamamoto N; Abe M; Mukherjee J; Hasegawa M; Pieper RO; Hirose Y
    Neurosurgery; 2020 Aug; 87(2):408-417. PubMed ID: 31833548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of IDH and TERTp mutation status using
    Ozturk-Isik E; Cengiz S; Ozcan A; Yakicier C; Ersen Danyeli A; Pamir MN; Özduman K; Dincer A
    J Magn Reson Imaging; 2020 Jun; 51(6):1799-1809. PubMed ID: 31664773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.
    Nagashima H; Tanaka K; Sasayama T; Irino Y; Sato N; Takeuchi Y; Kyotani K; Mukasa A; Mizukawa K; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
    Neuro Oncol; 2016 Nov; 18(11):1559-1568. PubMed ID: 27154922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.
    Zhang X; Tian Q; Wang L; Liu Y; Li B; Liang Z; Gao P; Zheng K; Zhao B; Lu H
    J Magn Reson Imaging; 2018 Oct; 48(4):916-926. PubMed ID: 29394005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of preoperative seizures with tumor metabolites quantified by magnetic resonance spectroscopy in gliomas.
    Nakae S; Kumon M; Murayama K; Ohba S; Sasaki H; Inamasu J; Kuwahara K; Yamada S; Abe M; Hirose Y
    Sci Rep; 2021 Apr; 11(1):7927. PubMed ID: 33846339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.
    Villanueva-Meyer JE; Wood MD; Choi BS; Mabray MC; Butowski NA; Tihan T; Cha S
    AJR Am J Roentgenol; 2018 Mar; 210(3):621-628. PubMed ID: 29261348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
    J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy.
    Natsumeda M; Igarashi H; Nomura T; Ogura R; Tsukamoto Y; Kobayashi T; Aoki H; Okamoto K; Kakita A; Takahashi H; Nakada T; Fujii Y
    Acta Neuropathol Commun; 2014 Nov; 2():158. PubMed ID: 25376594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.
    Miller JJ; Shih HA; Andronesi OC; Cahill DP
    Cancer; 2017 Dec; 123(23):4535-4546. PubMed ID: 28980701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    Eur Radiol; 2019 Feb; 29(2):745-758. PubMed ID: 30003316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis.
    Li Y; Qin Q; Zhang Y; Cao Y
    Curr Oncol; 2022 Sep; 29(10):6893-6907. PubMed ID: 36290819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas.
    Sonoda Y; Shibahara I; Kawaguchi T; Saito R; Kanamori M; Watanabe M; Suzuki H; Kumabe T; Tominaga T
    Brain Tumor Pathol; 2015 Apr; 32(2):99-104. PubMed ID: 25537428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
    Macaulay RJ
    Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative texture analysis in the prediction of IDH status in low-grade gliomas.
    Jakola AS; Zhang YH; Skjulsvik AJ; Solheim O; Bø HK; Berntsen EM; Reinertsen I; Gulati S; Förander P; Brismar TB
    Clin Neurol Neurosurg; 2018 Jan; 164():114-120. PubMed ID: 29220731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of IDH Status Through MRI Features and Enlightened Reflection on the Delineation of Target Volume in Low-Grade Gliomas.
    Ding H; Huang Y; Li Z; Li S; Chen Q; Xie C; Zhong Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819877167. PubMed ID: 31564237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.
    Chen R; Ravindra VM; Cohen AL; Jensen RL; Salzman KL; Prescot AP; Colman H
    Neurosurg Focus; 2015 Mar; 38(3):E2. PubMed ID: 25727224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.
    Andronesi OC; Loebel F; Bogner W; Marjańska M; Vander Heiden MG; Iafrate AJ; Dietrich J; Batchelor TT; Gerstner ER; Kaelin WG; Chi AS; Rosen BR; Cahill DP
    Clin Cancer Res; 2016 Apr; 22(7):1632-41. PubMed ID: 26534967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.